Gould Capital, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gould Capital, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,145
+18.2%
5000.0%0.01%
+22.2%
Q2 2023$11,125
+2.7%
5000.0%0.01%
+12.5%
Q1 2023$10,830
+6.6%
5000.0%0.01%0.0%
Q4 2022$10,155
-21.9%
5000.0%0.01%
-27.3%
Q3 2022$13,000
+8.3%
5000.0%0.01%
+10.0%
Q2 2022$12,000
+9.1%
5000.0%0.01%
+25.0%
Q1 2022$11,000
+10.0%
5000.0%0.01%
+14.3%
Q4 2021$10,0005000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders